Clinical Trial Update: Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial [Phase 2]

View source ↗

Summary

Phase II trial evaluating combined neoadjuvant systemic therapy with PIPAC for colorectal peritoneal metastasis in patients eligible for CRS and HIPEC; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colorectal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• PIPAC (Pressurized intraperitoneal aerosol chemotherapy)

Snippet

Sponsor: Prof. Aviram Nissan | Conditions: Metastatic Colorectal Cancer, Peritoneal Carcinomatosis | Phase 2 | Status: UNKNOWN